Nazione: Svizzera
Lingua: italiano
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
aesculus hippocastanum e semine rec. ferm 34c TM (HAB 34c), brassica nigra e semine sicca W 10% (HAB 12f), bryonia cretica ferm 33b (HAB) TM, dextrocamphora, cera flava, equisetum arvense ex herba sicc. ferm 35b TM (HAB 35b), formica rufa et formica polyctena ex animale toto Gl TM (HAB 41c), mel
WALA Schweiz AG
aesculus hippocastanum e semine rec. ferm 34c TM (HAB 34c), brassica nigra e semine sicca W 10% (HAB 12f), bryonia cretica ferm 33b (HAB) TM, dextrocamphora, cera flava, equisetum arvense ex herba sicc. ferm 35b TM (HAB 35b), formica rufa et formica polyctena ex animale toto Gl TM (HAB 41c), mel
Creme
aesculus hippocastanum e semine rec. ferm 34c TM (HAB 34c) 33 mg, brassica nigra e semine sicca W 10% (HAB 12f) 200 mg, bryonia cretica ferm 33b (HAB) TM 1 mg, dextrocamphora 10 mg, cera flava 117 mg, equisetum arvense ex herba sicc. ferm 35b TM (HAB 35b) 10 mg, formica rufa et formica polyctena ex animale toto Gl TM (HAB 41c) 1 mg, mel 20 mg, adeps lanae 180 mg, theobromatis oleum, arachidis oleum raffinatum 439.82 mg, glycerolum, aqua purificata, ad unguentum pro 1 g.
D
Antroposofici
Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)
zugelassen
2013-11-19